Literature DB >> 7482226

Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction.

P M Moore1, R P Lisak.   

Abstract

Neurologic complications of systemic lupus erythematosus (neuro-SLE) are common. The most frequent manifestations of neuro-SLE are seizures, encephalopathy, and behavioral changes, but a wide variety of other neurologic abnormalities affecting the central and peripheral nervous system and muscle also occur. Although the prevalence of neuro-SLE is high, the diversity of clinical presentations, the multiple potential etiologies, and the absence of sensitive and specific diagnostic tests render diagnosis difficult. Recent advances in understanding mechanisms of neuronal dysfunction combined with advances in imaging techniques, including functional imaging, should help in diagnosis and management. The mechanisms of neurologic injury can be divided into three broad categories. First, neuronal dysfunction may result from direct effects of the immune system on brain cells such as autoantibody binding to cell surface, immune complex deposition with secondary inflammation, and effects of cytokines. Second, immune- mediated injury to supportive structures such as the vasculature may also affect the nervous system by producing ischemia. Finally, the neuraxis may be affected by any one of several immune and non- immune effects of infection, toxins, and metabolic disturbances.

Entities:  

Mesh:

Year:  1995        PMID: 7482226     DOI: 10.1007/bf00194099

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  123 in total

1.  Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.

Authors:  R A Fields; W L Sibbitt; H Toubbeh; A D Bankhurst
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 2.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

3.  Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA/2 mice.

Authors:  H Jyonouchi; P W Kincade; R A Good; G Fernandes
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

4.  Are snRNPs involved in splicing?

Authors:  M R Lerner; J A Boyle; S M Mount; S L Wolin; J A Steitz
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

5.  The incidence and prognosis of central nervous system disease in systemic lupus erythematosus.

Authors:  J T Sibley; W P Olszynski; W E Decoteau; M B Sundaram
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

6.  Behavior, ectopias and immunity in BD/DB reciprocal crosses.

Authors:  V H Denenberg; G F Sherman; L Morrison; L M Schrott; N S Waters; G D Rosen; P O Behan; A M Galaburda
Journal:  Brain Res       Date:  1992-02-07       Impact factor: 3.252

7.  Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.

Authors:  Y Tanaka; K Saito; F Shirakawa; T Ota; H Suzuki; S Eto; U Yamashita
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

8.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979.

Authors:  C J Michet; C H McKenna; L R Elveback; R A Kaslow; L T Kurland
Journal:  Mayo Clin Proc       Date:  1985-02       Impact factor: 7.616

9.  The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients.

Authors:  A T Kaell; M Shetty; B C Lee; M D Lockshin
Journal:  Arch Neurol       Date:  1986-03

10.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; R S Cotran; M A Gimbrone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Neurology of the vasculitides and connective tissue diseases.

Authors:  P M Moore; B Richardson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

2.  Quantitative susceptibility mapping in patients with systemic lupus erythematosus: detection of abnormalities in normal-appearing basal ganglia.

Authors:  Atsushi Ogasawara; Shingo Kakeda; Keita Watanabe; Satoru Ide; Issei Ueda; Yu Murakami; Junji Moriya; Koichiro Futatsuya; Toru Sato; Shingo Nakayamada; Kazuyoshi Saito; Yoshiya Tanaka; Tian Liu; Yi Wang; Yukunori Korogi
Journal:  Eur Radiol       Date:  2015-08-01       Impact factor: 5.315

Review 3.  Dystonia and chorea in acquired systemic disorders.

Authors:  J L Janavs; M J Aminoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

4.  The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients With Systemic Lupus Erythematosus at Single-Cell Resolution.

Authors:  Haiyan Yu; Xiaoping Hong; Hongwei Wu; Fengping Zheng; Zhipeng Zeng; Weier Dai; Lianghong Yin; Dongzhou Liu; Donge Tang; Yong Dai
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

5.  Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke.

Authors:  Jozélio Freire de Carvalho; Sandra Gofinet Pasoto; Simone Appenzeller
Journal:  Clin Dev Immunol       Date:  2012-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.